Rocket Companies, Inc. declined 1.38% in premarket trading. The news event that aligns with this movement is the announcement by The Gross Law Firm regarding a class action lawsuit against Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). The lawsuit alleges that the company made misleading statements and concealed adverse facts concerning the true state of RP-A501's, which could negatively impact investor confidence and stock performance.
Comments
No comments yet